deltatrials
Completed OBSERVATIONAL NCT02000830

Follow up Study of Patients Having Participated in Clinical Trial 64,185-204 (JASMINE_205)

A Four-Year Blinded Outcomes Follow-up Study of Patients Who Received Stannsoporfin or Placebo in Clinical Trial 64,185-204

Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

Conditions Hyperbilirubinemia, Neonatal
Interventions Placebo Stannsoporfin
Updated 13 times since 2017 Last updated: Jan 28, 2021 Started: Oct 17, 2013 Primary completion: Feb 28, 2020 Completion: Feb 28, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hyperbilirubinemia, Neonatal, this trial is completed. The trial is conducted by InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company and has accumulated 13 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jan 2018 · 11 months · monthly snapshot~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Apr 2020 · 5 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Mar 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Mar 2021 [monthly]

    Completed

  5. Apr 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

▶ Show 8 earlier versions

  1. Nov 2019 — Apr 2020 [monthly]

    Active Not Recruiting

    Status: Enrolling By Invitation → Active Not Recruiting

  2. Sep 2019 — Nov 2019 [monthly]

    Enrolling By Invitation

  3. Jun 2018 — Sep 2019 [monthly]

    Enrolling By Invitation

  4. Apr 2018 — Jun 2018 [monthly]

    Enrolling By Invitation

    Phase: NA → None

  5. Mar 2018 — Apr 2018 [monthly]

    Enrolling By Invitation NA

  6. Jan 2018 — Mar 2018 [monthly]

    Enrolling By Invitation NA

  7. Feb 2017 — Jan 2018 [monthly]

    Enrolling By Invitation NA

  8. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation NA

    First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Data source: Mallinckrodt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.